Shannon Ronca

Baylor College Of Medicine

$4,823,396

Attributed

$7,323,327

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.8M · FY2021–25

$5M$3.8M$2.5M$1.3M$0

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$7,323,327 · 3

By mechanism

U19$3,842,980 · 1

RF1$3,039,032 · 1

R21$441,315 · 1

Top collaborators

Most similar at Baylor College Of Medicine

Same institution · by research overlap

Others in their field

Other Emerging Leaders on “Viral”

Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$160,855,334
Leonard Freedman · Leidos Biomedical Research, Inc.$68,911,178
John Damon Chodera · Sloan-Kettering Inst Can Research$51,025,260
Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$42,295,422
Timothy Fouts · Advanced Bioscience Laboratories, Inc.$41,541,738
Thomas Denny · Duke University$37,546,967

Research focus

ViralGenesVirusAlzheimer&AposCytokineTransgenic MiceReceptorReceptor CellPathologyInterleukin-1Clinical TrialsPathway InteractionsInfectionCovid-19AcidsFutureInflammatoryImmune2019-NcovCellsInterleukin-6MediatingPreventAce2

Grant awards (4)

SARS-CoV-2 initiation and acceleration of AD pathology in the setting of endogenous and exogenous risk factors$3,039,032

RF1 · FY2025 · NS

Project 3: Peribunyaviridae Pathogenesis and Vaccine Testing$3,842,980

U19 · FY2024 · AI · contact PI

Mechanisms of exacerbation of COVID-19 pathogenesis in mice expressing human ACE2 by polycyclic aromatic hydrocarbons (PAHs), and its protection by inhibition of soluble epoxide hydrolase (sEH)$200,595

R21 · FY2022 · ES

R21 · FY2021 · ES